Antibody therapy for acute myeloid leukaemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antibody therapy for acute myeloid leukaemia

Published:2013-12-10 Issue:4 Volume:164 Page:481-495
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Gasiorowski Robin E.¹²,Clark Georgina J.¹,Bradstock Kenneth¹³,Hart Derek N. J.¹

Affiliation:

1. ANZAC Research Institute; University of Sydney; Concord NSW Australia

2. Department of Haematology; Concord Cancer Centre; Concord Repatriation General Hospital; Concord NSW Australia

3. Blood and Marrow Transplant Service; Westmead Hospital; Westmead NSW Australia

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12691/fullpdf

Reference114 articles.

1. T lymphocytes can be effectively recruited for ex vivo and in vivo lysis of AML blasts by a novel CD33/CD3-bispecific BiTE((R)) antibody construct;Aigner;Leukemia,2013

2. IREM-1 is a novel inhibitory receptor expressed by myeloid cells;Alvarez-Errico;European Journal of Immunology,2004

3. Redirection of T cells with a first fully humanized bispecific CD33-CD3 antibody efficiently eliminates AML blasts without harming hematopoietic stem cells;Arndt;Leukemia,2013

4. Bispecific T-cell engaging antibodies for cancer therapy;Baeuerle;Cancer Research,2009

5. High levels of Wilms' tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome;Bergmann;Blood,1997

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and application of nanomaterials, nanotechnology and nanomedicine for treating hematological malignancies;Journal of Hematology & Oncology;2023-06-23

2. The complement receptor C3AR constitutes a novel therapeutic target in NPM1-mutated AML;Blood Advances;2023-03-31

3. Cell signaling pathways as molecular targets to eliminate AML stem cells;Critical Reviews in Oncology/Hematology;2021-04

4. CDK6 Is a Potential Prognostic Biomarker in Acute Myeloid Leukemia;Frontiers in Genetics;2021-02-01

5. Targeting CD300f to enhance hematopoietic stem cell transplantation in acute myeloid leukemia;Blood Advances;2020-03-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3